TY - JOUR
T1 - Prevalence and use of clinical pathways in 23 countries - An international survey by the European Pathway Association
AU - Vanhaecht, Kris
AU - Bollmann, Marcus
AU - Bower, Kathy
AU - Gallagher, Clare
AU - Gardini, Andrea
AU - Guezo, Jen
AU - Jansen, Uwe
AU - Massoud, Rashad
AU - Moody, Karen
AU - Sermeus, Walter
AU - Van Zelm, Ruben
AU - Whittle, Claire
AU - Yazbeck, Anne Marie
AU - Zander, Karen
AU - Panella, Massimiliano
PY - 2006/4
Y1 - 2006/4
N2 - Objectives: To give an overview on the use and prevalence of clinical pathways. Design: Cross-sectional descriptive study. Study participants: European Pathway Association (E-P-A) contact persons in 23 countries. Results: Clinical pathways, also known as critical pathways or integrated care pathways, have been used in health care for 20 years. Although clinical pathways are well established, little information exists on their use and dissemination around the world. The E-P-A has performed their first international survey on the use and dissemination of clinical pathways in 23 countries. At present, pathways are used with a minority of patients, mainly in acute hospital trusts. Our survey showed that clinical pathways were predominantly viewed as a multidisciplinary tool to improve the quality and efficiency of evidence-based care. Pathways were also used as a communication tool between professionals to manage and standardize outcome-oriented care. Conclusions: There is a future for the use of clinical pathways, but there is a need for international benchmarking and knowledge sharing with regard to their development, implementation and evaluation.
AB - Objectives: To give an overview on the use and prevalence of clinical pathways. Design: Cross-sectional descriptive study. Study participants: European Pathway Association (E-P-A) contact persons in 23 countries. Results: Clinical pathways, also known as critical pathways or integrated care pathways, have been used in health care for 20 years. Although clinical pathways are well established, little information exists on their use and dissemination around the world. The E-P-A has performed their first international survey on the use and dissemination of clinical pathways in 23 countries. At present, pathways are used with a minority of patients, mainly in acute hospital trusts. Our survey showed that clinical pathways were predominantly viewed as a multidisciplinary tool to improve the quality and efficiency of evidence-based care. Pathways were also used as a communication tool between professionals to manage and standardize outcome-oriented care. Conclusions: There is a future for the use of clinical pathways, but there is a need for international benchmarking and knowledge sharing with regard to their development, implementation and evaluation.
UR - http://www.scopus.com/inward/record.url?scp=33646745130&partnerID=8YFLogxK
U2 - 10.1258/j.jicp.2006.124
DO - 10.1258/j.jicp.2006.124
M3 - Article
SN - 1473-2297
VL - 10
SP - 28
EP - 34
JO - Journal of Integrated Care Pathways
JF - Journal of Integrated Care Pathways
IS - 1
ER -